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Background: A risk-targeted prevention strategy may efficiently utilize limited resources available for prevention of
overweight and obesity. Likewise, more efficient intervention trials could be designed if selection of subjects was
based on risk. The aim of the study was to develop a risk score predicting substantial weight gain among German
adults. Methods: We developed the risk score using information on 15 socio-demographic, dietary and lifestyle
factors from 32 204 participants of five population-based German cohort studies. Substantial weight gain was
defined as gaining10% of weight between baseline and follow-up (>6 years apart). The cases were censored
according to the theoretical point in time when the threshold of 10% baseline-based weight gain was crossed
assuming linearity of weight gain. Beta coefficients derived from proportional hazards regression were used as
weights to compute the risk score as a linear combination of the predictors. Cross-validation was used to evaluate
the score’s discriminatory accuracy. Results: The cross-validated c index (95% CI) was 0.71 (0.67–0.75). A cutoff value
of 475 score points yielded a sensitivity of 71% and a specificity of 63%. The corresponding positive and negative
predictive values were 10.4% and 97.6%, respectively. Conclusions: The proposed risk score may support healthcare
providers in decision making and referral and facilitate an efficient selection of subjects into intervention trials.
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Introduction
Obesity increases morbidity and, consequently, entails a largesocietal and economic burden.1–3 Considering the limited
resources, a risk-targeted prevention strategy may efficiently
complement a population-based approach.4 Prevention efforts may
be specifically targeted at those individuals with high risk of
developing overweight or obesity. High-risk individuals can be
identified using risk prediction models that combine information
on multiple characteristics to estimate the individual’s risk of a
future outcome. While there are numerous prediction models to
estimate the risk of cardiovascular disease, type 2 diabetes and
cancer,5–8 models predicting weight gain are scarce.
We recently presented a risk score to predict substantial weight
gain (SWG) among European adults based on 13 socio-demo-
graphic, dietary and lifestyle factors.9 This European obesity risk
score exhibited a rather low discriminatory accuracy [c index
(95% CI) of 0.64 (0.63–0.65) and 0.57 (0.56–0.58) in the develop-
ment and validation sample, respectively]. Interestingly, we observed
remarkable variation in performance across different socio-cultural
backgrounds, i.e. across countries, while study centers assumed to
have a similar underlying socio-cultural structure showed
comparable performance. Hence, the approach to first develop
country-specific prediction models and subsequently compare
them across socio-cultural backgrounds could be a successful
strategy.5
Based on data from five population-based German,cohort studies,
we developed and validated a risk score predicting SWG, the
German obesity risk score (GORS). Given the importance of
abdominal fat in relation to metabolic diseases10, we additionally
evaluated a risk score predicting gain in waist circumference
beyond gain in BMI.
Methods
Study population
The study is based on five population-based longitudinal German
cohorts comprising participants from the national cohort from the
German Health Interview and Examination Survey for Adults
(DEGS) and participants from four regional cohorts including the
two German cohorts of the EPIC study based in Potsdam and
Heidelberg, the Study of Health In Pomerania (SHIP) and the
Cooperative Health Research in the Region of Augsburg (KORA)
S4 Study. Detailed information on these studies has already been
described.11–15 In brief, participants for all studies were recruited
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from the general population as a random sample from the respective
population registries. The study population from DEGS virtually
covered the whole adult life span (18–79 years). The age ranges
for SHIP, KORA and EPIC-Germany were 20–79, 25–74 and 35–
65 years at baseline, respectively. From the 68 781 men and women
recruited between 1994 and 2001, a total of 55 689 were followed up
between 2004 and 2012 (participation rate varied between 43% in
DEGS and 89% in EPIC-Potsdam). Of these, 32 204 individuals were
finally used in the present study (for exclusions, see figure 1). Briefly,
individuals were excluded if follow-up information was not
available, anthropometric data were missing, if they were pregnant
at baseline or follow-up or if they reported diabetes, cardiovascular
diseases or cancer at baseline. To minimize confounding from
changes in body composition and shape occurring in older age,
our study was restricted to participants aged <70 years at follow-
up. Further exclusions refer to participants with general or
abdominal obesity at baseline (BMI30 kg/m2; waist circumference
of102 cm and88 cm among men and women, respectively) and
to participants with missing values in any exclusion criteria or
covariate (<2% except for DEGS).
Ethics statement
All studies were conducted conforming to the principles of the
Declaration of Helsinki. The regional studies were approved by
the local ethics committees. The study protocol of DEGS was
consented with the Federal and State Commissioners for Data
Protection and approved by the Charité-Universitätsmedizin
Berlin ethics committee. All participants provided written
informed consent.
Assessment of anthropometry
At baseline, body weight and height were measured by trained staff
following standardized procedures in all cohorts. Measurements
were obtained without shoes and in underwear (EPIC) or light
clothing (SHIP, KORA and DEGS). At follow-up, body weight was
measured according to the same measurement procedures in SHIP
and KORA. In follow-up of DEGS, participants were only wearing
underwear for anthropometric measurements. In EPIC, body weight
was self-reported at follow-up, and we applied prediction equations
to correct for potential misreporting.16
Assessment of diet and lifestyle
In KORA, SHIP and DEGS usual frequency of intake over the past
12 months was assessed by means of short questionnaires including
around 40 food items covering the main food groups. In EPIC,
habitual diet in the past 12 months was assessed using a validated
food frequency questionnaire.17 Dietary information was
harmonized across the five cohorts and expressed as frequency of
consumption using three categories per food item. Across cohorts,
socio-demographic, lifestyle and further health-related characteris-
tics were assessed in a comparable manner by means of extensive
questionnaires, face-to-face interviews and/or computer-assisted
interviews.
Statistical analysis
Definition of cases and time-to-event
SWG was defined as gaining10% of baseline weight during follow-
up, as described previously.9 Each participant was followed up for
incidence of SWG from study entry to the second assessment of
body weight (end of follow-up). Those individuals who did not
experience SWG during follow-up were censored at time of their
second weight assessment and participants experiencing SWG
constituted the set of cases. We estimated the time theoretically
needed for the cases to cross the threshold of10% baseline-based
weight gain by assuming linear weight gain.
Figure 1 Flow diagram of participants excluded from the present study. aNo follow-up questionnaire (e.g. due to death before follow-up,
emigration or non-response to invitation). bMissing data on baseline or follow-up body weight, waist circumference or body height.
cPregnancy at baseline or follow-up; dBaseline diabetes, cardiovascular disease or cancer. eDefinition of general obesity: BMI 30 kg/m2;
definition of abdominal obesity: WCmen 102 cm, WCwomen 88 cm.
fInsufficient information (e.g. "don’t know") in assessment of
pregnancy or sleep disorders
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Definition of predictors
In addition to all predictors forming the European obesity risk
score,9 we included intake of fruits and vegetables, chocolate and
sleep disorders as predictors in the GORS. Because intake of meat
types was not available in DEGS, we used a single variable repre-
senting total meat intake. Similarly, information on whole-grain
bread was not available in EPIC-Heidelberg and SHIP, and we
used intake of non-white bread in these cohorts.
Construction of the GORS
The GORS was derived using a proportional hazards model to
account for diverse follow-up times between participants and
individual velocities of weight gain. To best reflect the association
of predictors with SWG in the German population, we used a meta-
analytical approach to develop the risk score function. Specifically,
cohort-specific  coefficients of the 15 predictors were estimated and
combined using random-effects meta-analysis.18 Score points
(weights) for each predictor were assigned based on the value of
the corresponding pooled  coefficients multiplied by 100 and
rounded to two decimal places. For each individual, a risk score
(RSi) was computed as a linear combination of the weighted
predictors. The score was rescaled by adding 800. The individual
probability of gaining10% of weight in the following 5 years
(P(SWG, 5y)i) was computed by inserting the individual risk score
(RSi) into the survival function of the proportional hazards model.
For this, the cohort-specific background survival probabilities at 5
years were estimated based on the average value of each predictor
over all individuals of the five cohorts and subsequently meta-ana-
lytically combined.
Evaluation of the GORS
Discrimination was assessed by the c index for time-to-event
analysis.19 We applied 10-fold cross-validation by estimating the
risk score function in (all combinations of) two cohorts and
testing it in the remaining three, respectively. Calibration was
evaluated by comparing observed and predicted risk across
categories of predicted risk estimated over all cohorts. To propose
a threshold value of the continuous GORS to define high-risk indi-
viduals, we used the Youden’s index.20 Following Menke,21, 22 we
applied bivariate random-effects meta-analysis to pool cohort-
specific sensitivities and specificities for a range of possible cut-off
points of the GORS.
Statistical analyses were performed in SAS, version 9.4 (SAS
Institute, Cary, NC). Meta-analyses were conducted using the
package "meta" developed by Schwarzer23 for R software (version
3.2.3).
Risk score predicting substantial gain in waist
circumference beyond gain in BMI
We additionally constructed a risk score predicting substantial gain
in waist circumference beyond gain in BMI defined on the basis of
the residuals of waist circumference regressed on BMI (WCBMI),
thus specifically reflecting gain in abdominal fat. Substantial gain
in WCBMI was defined as gaining3.5 cm of baseline WCBMI
during follow-up. Height and baseline waist circumference were
included in this model additionally to the 15 predictors from the
GORS.
Results
The present study included 32 204 individuals and the average
follow-up ranged from 6.9 years (KORA) to 10.9 years (DEGS)
(table 1). A total of 1661 individuals (5.1%) gained10% of their
baseline weight within 5 years after baseline, with 66 (5.0%), 67
(4.4%), 89 (5.3%), 504 (4.1%) and 935 (6.0%) in SHIP, DEGS,
KORA, EPIC-Heidelberg and EPIC-Potsdam, respectively. The
overall incidence rate amounted to 241 per 10 000 person-years
(PY). Across cohorts, incidence rate was highest in SHIP and
EPIC-Potsdam (295 and 277 per 10 000 PY, respectively) while it
was lowest in KORA and EPIC-Heidelberg (196 and 198 per 10 000
PY, respectively) (data not shown). On average, study participants
gained 299 g (KORA) to 429 g (EPIC-Potsdam) weight per year
(table 1). Individuals from SHIP and DEGS were on average
younger than participants in the other cohorts, proportion of men
was highest in KORA and DEGS (almost 50%), while in EPIC-
Potsdam, it was lowest (37%).
The meta-analytically combined estimates of relative risk for the
association of the predictors with SWG and corresponding score
points are shown in table 2. As for single predictors, baseline age
and weight most strongly determined risk, indicating a lower risk for
future weight gain with increasing age and weight.
Under average conditions 96% of the population will not
experience SWG within 5 years (average survival probability at 5
years = 0.9634). The individual risk of gaining10% of baseline
weight within 5 years (P(SWG, 5y)i) was estimated by inserting the
individual risk score points into the following survival function:
PðSWG;5yÞi ¼ 1 0:9634þ exp
ððRSi440:94Þ=100Þ
The median of the GORS across the five cohorts was 439, ranging
from 269 to 684. The probability of experiencing SWG within the
following 5 years for 350, 400, 450, 500 and 550 score points was 1.5,
2.4, 4.0, 6.5 and 10.5%, respectively. The cross-validated c index
(95% CI) was 0.71 (0.67–0.75). While discriminatory ability was
quite similar among four of the five cohorts, ranging from 0.68
(0.67–0.70) in EPIC-Potsdam to 0.72 (0.66–0.78) in SHIP, discrim-
ination was strikingly higher in DEGS [0.79 (0.74–0.84)] (data not
shown). Table 3 displays pooled sensitivity and specificity across a
range of possible cut-off points of the GORS. Sensitivity and speci-
ficity were maximized at a score value of475 (Youden’s index of
0.34). This threshold captured 71% of the cases who experienced
SWG. Likewise, 63% of individuals who did not experience SWG
had a score below this threshold. The corresponding positive and
negative predictive values were 10.4% and 97.6%, respectively,
implying that around 10% of individuals with a score value
of475 in fact experience SWG, while almost 98% of individuals
having a score below 475 remain free of SWG.
Observed incidence was largely comparable with predicted risk
across the total study population (data not shown). Within
cohorts, we observed very good calibration in KORA and SHIP,
good to acceptable calibration in the EPIC cohorts with underesti-
mation of risk in the higher risk groups and overestimation in
DEGS.
A total of 3095 individuals showed substantial gain in WCBMI
within 5 years after baseline (256 cases per 10 000 PY). The cross-
validated c index (95% CI) of the model predicting substantial gain
in WCBMI was 0.70 (0.65–0.74). Within cohorts, discrimination
varied between 0.65 (0.61–0.69) in KORA to 0.78 (0.70–0.86) in
SHIP. Calibration was heterogeneous across cohorts, ranging from
very good calibration in EPIC-Heidelberg to poor calibration in
EPIC-Potsdam, SHIP and DEGS. Importantly, while dietary and
lifestyle predictors mostly showed associations of similar direction
compared with the GORS, the relationship of the most influential
predictors age, sex and weight was reversed when predicting sub-
stantial gain in WCBMI [HR (95% CI) of 1.04 (1.03–1.04), 0.53
(0.32–0.90) and 1.17 (1.15–1.20), respectively].
Discussion
In this multi-center prospective study, we presented a risk score to
predict SWG within the next 5 years. The GORS is based on data
from five population-based German cohort studies, representing
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four different regions and Germany as a whole, thereby including a
diverse structure of predictors. Discriminatory accuracy and calibra-
tion of the GORS encourage its application in practice. Specifically,
the GORS may be used to identify subgroups that would benefit
most from risk-reducing interventions or might help to design
more efficient intervention studies by specifically selecting
high(er)-risk individuals.
Major strengths of the present study are its prospective, multi-
center design, the large sample size and the availability of informa-
tion on a variety of predictors. Given the meta-analytical approach
followed by cross-validation with non-random splits, our results can
be considered generalizable, i.e. externally validated.
As a limitation, we relied on only two assessments of body weight
and assumed weight gain to be linear. On the population-level,
however, weight gain can be reasonably well approximated by a
straight line over a follow-up period of 8 years.24 In SHIP, KORA
and DEGS, body weight was assessed by trained staff at both assess-
ments, while in EPIC body weight was self-reported at follow-up.
These methodological differences were accounted for by correcting
self-reported body weight using prediction equations.16 As in most
epidemiological studies, random error and self-reporting bias in
dietary and lifestyle factors might have affected our results.
Specifically, we lacked information on objectively measured
physical activity and therefore restricted information to sports
which has been demonstrated to be more accurately recalled than
low-intensity behaviors.25 Also, because information on portion size
was not available in all cohorts, information on dietary predictors
was restricted to frequency of consumption. It is well known though
Table 1 General characteristics of the study population
EPIC-Potsdam EPIC-Heidelberg SHIP KORA DEGS
n 15 465 12 229 1318 1671 1521
Duration of follow-up (y) 8.0 (1.5) 8.2 (1.3) 10.1 (2.2) 6.9 (0.8) 10.9 (2.3)
Cases within 5 years (N) 935 504 66 89 67
Age at baseline (y) 47.3 (8.0) 48.6 (7.4) 39.7 (10.8) 43.0 (10.5) 39.2 (10.6)
Age range at baseline, median (IQR) 46.0 (41.0–55.0) 48.0 (42.0–55.0) 39.0 (31.0–49.0) 42.0 (34.0–51.0) 39.0 (31.0–48.0)
Men (%) 37.2 44.6 45.1 49.9 47.6
University degree (%) 41.6 36.5 13.3 20.1 19.5
Anthropometry
BMI baseline (kg/m2) 24.3 (2.6) 24.1 (2.7) 24.4 (2.8) 24.6 (2.7) 24.1 (2.7)
BMI follow-up (kg/m2) 25.6 (3.1) 25.2 (3.4) 26.1 (3.4) 25.2 (3.0) 25.5 (3.4)
Obese at follow-up (%) 7.6 5.9 14 5.9 9.3
Annual weight change (g/year) 429 (588) 359 (723) 388 (560) 299 (661) 310 (536)
Lifestyle factors and health-related factors
Sports (%)
0 h/wk 56.3 37.5 41.1 25.4 33.7
>0 to < 2 h/wk 18.9 20.9 35.3 49.8 41.6
2 h/wk 24.8 41.6 23.6 24.8 24.7
Current smoking (%) 20.8 22.4 33.9 29.1 33.8
Alcohol consumption (%)
0 g/day 2.4 4.2 28.7 23.2 12.5
>0 to6 g/day 37.5 31.8 22 23.2 47.7
>6 to18 g/day 32.9 29.3 22.3 19.6 22.2
>18 g/day 27.2 34.6 27 34 17.6
Sleep disorders (%) 13.4 11.9 16.8 17.2 16
Dietary factors
Fruits and vegetables (%)
<1 time/day 14.3 34.5 56.4 52.4 51.2
1 time to < 2 times/day 17.5 26.4 25.8 23.5 19
2 times/day 68.2 39.1 17.8 24.1 29.9
Meat (%)
<4–6 times/week 12.2 58.3 20.9 39 27.8
4–6 times/week to < 1 time/day 12 20.6 19.2 27.4 31.6
1 time/day 75.8 21.1 59.9 33.7 40.6
Fish (%)
<2–3 times/month 17.9 38.6 34.8 32.7 22.8
2–3 times/month to < 1 time/week 24 23.2 30.1 28.1 25.2
1 time/week 58.1 38.2 35.1 39.1 52.1
Whole grain bread (%)a
<2–3 times/week 49.6 9.4 6.4 30.2 33.4
2–3 to < 4–6 times/week 17.1 15.4 7.5 33.2 26
4–6 times/week 33.3 75.3 86.1 36.6 40.6
Cake and cookies (%)
<1 time/week 15.6 19.3 32.1 32 21.1
1 to < 2–3 times/week 33.3 31.1 29.6 30 33.5
2–3 times/week 51.2 49.7 38.3 38 45.3
Chocolate (%)
<1 time/week 22.4 29.5 42.6 37.7 27.4
1 to < 2–3 times/week 23.8 19.6 17.6 22.2 24.1
2–3 times/week 53.8 50.9 39.8 40.1 48.6
Soft drinks (%)
<2–3 times/month 70.8 69.9 56.6 56.3 40.6
2–3 times/month to 4–6 times/week 23.1 20.2 28.5 30.9 38.1
4–6 times/week 6.2 9.9 15 12.9 21.3
Notes. For continuous variables mean (SD) are shown. aIn EPIC-Heidelberg and SHIP non-white bread was used instead of whole grain bread.
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that frequency of consumption explains a larger part of inter-
individual variation in food intake than inter-individual variation
in portion size.26
In a prediction model, associations of predictors with the
outcome may not necessarily reflect etiological relationships.27 In
the present study, this may particularly apply to education,
smoking and intake of cake and cookies. Educational level is an
indicator of acquisition of knowledge and competences that
enables individuals to integrate a health-promoting lifestyle.28
Thus, education may reflect further aspects of dietary and lifestyle
behavior in addition to the behavioral factors in the model. For
smoking, which is generally related to lower BMI compared with
non-smoking,29 the higher risk of SWG among baseline smokers can
be attributed to the higher risk of weight gain among those individ-
uals who quit smoking during follow-up compared with those who
continued smoking, an observation discussed previously.9, 29 In
EPIC-Potsdam, for instance, 35% of baseline smokers stopped
smoking during follow-up and showed a substantially higher
annual weight gain than continuing smokers (770 g/y vs. 422 g/y).
Accordingly, smoking cessation during follow-up was related to a
significantly higher risk of SWG than continuing smoking
(HRs (95% CI) compared with constant non-smoking of [2.53
(2.28–2.80) and 0.97 (0.87–1.08), respectively]. Lastly, the inverse
association of cake and cookies with SWG might reflect selective
Table 2 Meta-analytically derived estimates for the association of predictors with SWG and associated score points
Predictors HR (95% CI) Score points
Age (years) 0.96 (0.96–0.97) -0.0408 -4.1
Sex (female vs. male) 1.10 (0.99–1.24) 0.0953 9.5
Baseline weight (kg) 0.98 (0.98–0.99) -0.0202 -2.0
Education
Secondary/Professional school 0.88 (0.79–0.98) -0.1278 -12.8
University 0.76 (0.70–0.82) -0.2744 -27.4
Lifestyle and health-related factors
Sports
>0 to < 2h/wk 0.93 (0.87–0.99) -0.0726 -7.3
2h/wk 0.89 (0.77–1.02) -0.1165 -11.7
Smoking 1.48 (1.40–1.56) 0.392 39.2
Alcohol
No alcohol 1.08 (0.90–1.29) 0.077 7.7
Alcohol >6 to18g/d 0.88 (0.83–0.94) -0.1278 -12.8
Alcohol >18g/d 0.89 (0.80–0.99) -0.1165 -11.7
Sleep disorders 1.28 (1.20–1.38) 0.2469 24.7
Dietary factors
Fruits and vegetable
1 time to < 2 times/day 0.94 (0.87–1.01) -0.0619 -6.2
2 times/day 0.96 (0.86–1.06) -0.0408 -4.1
Meat
4–6 times/week to < 1 time/day 1.07 (0.97–1.18) 0.0677 6.8
1 time/day 1.11 (1.01–1.22) 0.1044 10.4
Fish
2–3 times/month to < 1 time/week 0.98 (0.90–1.06) -0.0202 -2.0
1 time/week 0.99 (0.90–1.09) -0.0101 -1.0
Whole-grain bread
2–3 to < 4–6 times/week 0.94 (0.87–1.02) -0.0619 -6.2
4–6 times/week 0.87 (0.81–0.93) -0.1393 -13.9
Cake and cookies
1 to < 2–3 times/week 0.88 (0.75–1.02) -0.1278 -12.8
2–3 times/week 0.76 (0.61–0.96) -0.2744 -27.4
Chocolate
1 to < 2–3 times/week 1.05 (0.97–1.13) 0.0488 4.9
2–3 times/week 1.03 (0.96–1.12) 0.0296 3.0
Soft drinks
2–3 times/month to 4–6 times/week 1.11 (1.04–1.18) 0.1044 10.4
4–6 times/week 1.18 (1.03–1.34) 0.1655 16.6
Table 3 Pooled sensitivity and specificity and associated test characteristics across a range of possible cut-off points of the German Risk






(95% CI), in %
Specificity
(95% CI), in %
Youden’s
index
PPV (%) NPV (%) LR + LRto
400 2.4 74.8 96 (90–99) 19 (9–30) 0.15 6.4 98.9 1.2 0.2
425 3.1 59.4 91 (78–98) 32 (16–51) 0.23 7.3 98.5 1.3 0.3
450 4.0 42.7 82 (61–95) 47 (28–67) 0.29 8.4 98.0 1.5 0.4
475 5.1 27.8 71 (42–91) 63 (41–81) 0.34 10.4 97.6 1.9 0.5
500 6.5 15.5 52 (24–80) 77 (56–90) 0.29 12.3 96.7 2.3 0.6
525 8.3 7.6 34 (12–64) 87 (71–96) 0.21 14.2 96.0 2.6 0.8
Youden’s Index = (sensitivity (%) + specificity (%) – 100)/100. PPV = positive predictive value. NPV = negative predictive value. LR + =likelihood
ratio positive. LR-=likelihood ratio negative.
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underreporting of intake. In a sub-study of EPIC-Potsdam, for
instance, the inverse association of cake and cookies with BMI was
reversed when underreporting was accounted for.30
The observed variation in calibration between cohorts may be
explained by the different background risks. For example, in those
cohorts where the cohort-specific estimate of background risk
resembled the pooled estimate, calibration was very good (KORA
and SHIP), while in cohorts where the cohort-specific background
risk was higher than the pooled one (EPIC cohorts), the GORS
generally underestimated risk. Differences in outcome frequency
are often observed between diverse populations, and adjusting the
baseline risk has been suggested as a simple method of improving
calibration.31
The GORS exhibited a higher discrimination than its European
counterpart9 though predictive performance was still moderate.
Given the wide range of predictors in our model, it is unlikely
that further (strong) predictors have been missed. Also, additional
predictors would have to show very large "independent" associations
to meaningfully increase discrimination of an already reasonably
good model.32 The nature of weight gain per se may challenge its
prediction. Weight gain is reversible, and it is well-known that body
weight tends to fluctuate over time, leading to repeated cycles of
weight loss and recovery.33, 34 In some instances, these fluctuations
may exacerbate accurate classification of cases, non-cases and the
cases’ time-to-event, limiting the predictability.
We suggested a cut-off value of475 for practical application of
the GORS, i.e. individuals exceeding this threshold may be advised
to undergo weight management programs. The threshold value was
based on the maximization of both sensitivity and specificity while
both characteristics were regarded as equally important. In practice,
however, the cut-off value should be chosen according to the
importance attached to false-positives and false-negatives. In
contrast to more severe diseases such as cancer or CVD, misclassi-
fication costs may essentially reduce to the costs attached to false-
positives in the context of weight gain prediction. False-positives
may pose a large economic burden to the healthcare system since
a considerable number of individuals will be unnecessarily advised to
undergo prevention programs. Thus, for application of the GORS, a
cut-off point related to higher specificity may be preferred.
Interestingly, a different group of individuals is defined as "high-
risk" when predicting substantial gain in WCBMI, as a measure of
abdominal obesity, compared with SWG. While the GORS is more
likely to identify individuals who are younger, female and have lower
body weights to be at high risk, the WCBMI model assigns higher
risks to older, male and heavier individuals. This finding is in line
with the observation of sex-specific patterns of body fat gain and fat-
redistribution associated with aging.35, 36 In terms of metabolic
disease risk and longevity10, 37, body fat distribution, i.e. higher
visceral fat vs. subcutaneous fat, and the relationship of body com-
partments to each other, i.e. muscle vs. fat mass, may be important.
Thus, future studies may direct research efforts toward the
prediction of particular body composition phenotypes to enable a
more specific identification of individuals at high metabolic risk.
Our proposed risk score predicting SWG based on easily
obtainable information was shown to have adequate discriminatory
accuracy and calibration. The GORS may be used to support
healthcare providers in decision making and referral. Future inter-
vention studies may apply the GORS to facilitate an efficient
selection of study participants.
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Key points
 Prevention of overweight and obesity is a major public
health challenge.
 A risk-targeted prevention strategy may more efficiently
utilize limited resources available for prevention than a
population-based strategy.
 Currently, there are no tools to accurately identify high-risk
individuals for targeted prevention.
 The present study presents a simple, but adequate tool by
which individuals at high risk of experiencing SWG within
the next 5 years can be distinguished from individuals at low
risk.
 The tool may support healthcare providers in decision
making and referral and facilitate an efficient selection of
study participants into clinical trials.
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